Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines

Journal of Endocrinological Investigation

Volumn 33, Issue 1, 2010, Pages 2-6

  Sponziello, M ^a   Scipioni, A ^a   Durante, C ^a   Verrienti, A ^a   Maranghi, M ^a   Giacomelli, L ^a   Ferretti, E ^a   Celano, M ^b   Filetti, S ^a   Russo, D ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Breast cancer cells; Lactoperoxidase; Real time PCR; Retinoic acid; Sodium iodide symporter

Indexed keywords

BRCA1 PROTEIN; BUTYRIC ACID; DEXAMETHASONE; LACTOPEROXIDASE; MESSENGER RNA; RETINOIC ACID; SODIUM IODIDE SYMPORTER; TRICHOSTATIN A;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; REAL TIME POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; BUTYRATES; CELL LINE, TUMOR; DEXAMETHASONE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; LACTOPEROXIDASE; RNA, MESSENGER; SYMPORTERS; TRETINOIN;

EID: 77950535700     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6522     Document Type: Article

References (22)

1. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379: 458-460
2. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999, 141: 443-457
3. Schlumberger M, Lacroix L, Russo D, Filetti S, Bidart JM. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nat Clin Pract Endocrinol Metab 2007, 3: 263-269
4. Kogai T, Taki K, Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocr Rel Cancer 2006, 13: 797-826.
5. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000, 6: 871-888
6. Dohén O, De la Vieja A, Parader V, et al. The Sodium/Iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003, 24: 48-77.
7. Bruno R, Giannasio P, Ronga G, et al. Sodium iodide symporter expression and radioiodine distribution in extra-thyroidal tissues. J Endocrinol Invest 2004, 27: 1010-1014
8. Etling N, Gehin-Fouque F. Iodinated compounds and thyroxine binding to albumin in human breast milk. Ped Res 1984, 18: 901-903
9. Charafe-Jauffret E, Ginestier C, Monville F, et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006, 25: 2273-2284
10. Ferretti E, Tosi E, Po A, et al. Notch signaling is involved in expression of thyroid differentiation markers and is downregulated in thyroid tumors. J Clin Endocrinol Metab 2008, 93: 4080-4087
11. Hortobagyi GN. Treatment of breast cancer. N Engl J Med 1998, 339: 974-984
12. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 2006, 155: 495-512.
13. Kogai T, Kanamoto Y, Che LH, et al. Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models. Cancer Res 2004, 64: 415-422
14. Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, et al. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Br Cancer Res Treat 2008, 109: 263-272
15. Tanosaki S, Ikezoe T, Heaney A, et al. Effects of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Br Cancer Res Treat 2003, 79: 335-345
16. Tomlinson GE, Chen TTL, Stastny VA, et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation camer. Cancer Res 1998, 58: 3237-3242
17. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci U S A 2000, 97: 8519-8524
18. Puppin C, D'Aurizio F, D'Elia AV, et al. Effects of histone acetylation on NIS promoter and expression of thyroid-specific transcription factors. Endocrinology 2005, 146: 3967-3974
19. Peyrottes I, Navarro V, Ondo-Mendez A, et al. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers. Eur J Endocrinol 2009, 160: 215-225
20. Strum JM, Phelps PC, McAtee MM. Restin human female breast tissue produces iodinated proteins. J Ultrastruct Res 1983, 84: 130-139
21. Boland A, Magnon C, Filetti S, et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Thyroid 2002, 12: 19-26.
22. Iwamoto KS. The mechanistic role of iodine in breast carcinogenesis. U.S. Army Medical Research and Materiel Command, Fort Detrick, Maryland, Award number: W81XWH-04-1-0684, 1-08-2005.